BCD101 Safety Study in Healthy Volunteers
Part of Heart & circulation clinical trials.
This trial tests the safety of a new drug called BCD101 in healthy people. It checks how the drug moves through the body and if it causes any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult aged 19 or older.
- You weigh at least 50 kg (about 110 lbs) and have a body mass index (BMI) between 18 and 30.
- You have no major health conditions (like heart, liver, or kidney problems) and are not taking regular medications.
- You are not pregnant, planning to become pregnant, or breastfeeding, and you agree to use reliable birth control if needed.
- You can avoid certain foods and drinks (like grapefruit, caffeine, and alcohol) and strenuous exercise during the study.
- You have not donated blood or participated in another drug trial in the past few months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, BR1015, to see how it moves through the body and if it is safe. It is for healthy adults who are willing to fast before taking the medicine.
This trial tests how the body processes a new drug combination (BR1015-A vs. BR1015-3 and BR1015-2 taken together) in healthy volunteers. It helps researchers understand the safety and drug levels in the blood when taken on an empty stomach.
This trial tests a new medicine (BR1015-A) taken with food and compares it to taking two other medicines together. It is for healthy volunteers to see how the drug moves through the body and if it is safe.
This trial tests a new medicine called BR1015-A. It compares how the body handles the medicine when given alone versus as two separate parts taken together. The study is done after eating to see how food affects the drug.
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
This trial tests a new medicine called BCD-261 in healthy men to see if it is safe and how the body processes it. Participants will receive increasing doses and be monitored for about 4 months.
Hear when a new Essential Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.